Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prenetics Global (PRE) Research & Development (2021 - 2025)

Prenetics Global has reported Research & Development over the past 5 years, most recently at -$743000.0 for Q4 2025.

  • Quarterly Research & Development rose 64.75% to -$743000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.1 million through Dec 2025, up 45.86% year-over-year, with the annual reading at $5.1 million for FY2025, 43.3% down from the prior year.
  • Research & Development was -$743000.0 for Q4 2025 at Prenetics Global, up from -$1.2 million in the prior quarter.
  • Over five years, Research & Development peaked at -$743000.0 in Q4 2025 and troughed at -$5.5 million in Q4 2021.
  • The 5-year median for Research & Development is -$2.2 million (2022), against an average of -$2.3 million.
  • Year-over-year, Research & Development surged 73.2% in 2022 and then crashed 402.64% in 2023.
  • A 5-year view of Research & Development shows it stood at -$5.5 million in 2021, then surged by 73.2% to -$1.5 million in 2022, then crashed by 76.79% to -$2.6 million in 2023, then rose by 18.5% to -$2.1 million in 2024, then soared by 64.75% to -$743000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRE's Research & Development are -$743000.0 (Q4 2025), -$1.2 million (Q3 2025), and -$1.2 million (Q2 2025).